U.S. vaping-related deaths rise to 54, hospitalizations to 2,506
Reuters
Published Dec 19, 2019 02:15PM ET
U.S. vaping-related deaths rise to 54, hospitalizations to 2,506
(Reuters) - U.S. health officials said on Thursday two more deaths occurred since last week from a mysterious respiratory illness tied to vaping, taking the total toll to 54.
The Centers for Disease Control and Prevention (CDC) also reported 97 more hospitalized cases from 50 states, the District of Columbia, and two U.S. territories, as of Dec. 17. The number of people hospitalized now stands at 2,506.
The deaths have been confirmed in 27 states and the District of Columbia, and the CDC said more deaths are under investigation.
U.S. officials in November reported the discovery of Vitamin E acetate — believed to be used as a cutting agent in illicit vaping products containing marijuana components — in all lung samples from 29 patients.
CDC has called Vitamin E acetate as a "chemical of concern" and recommended the substance not be added to e-cigarette, or vaping products, while the investigation is ongoing.
Get The News You Want
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.